Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 7, 2020

ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato

Specialist HIV company ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its Dovato (dolutegravir/lamivudine) as a complete regimen to treat HIV-1 infection.

Continue
ViiV Healthcare has secured FDA expanded approval for HIV-1drug Dovato. (Credit: Business Wire)
August 6, 2020

GSK secures FDA nod for BLENREP to treat relapsed or refractory multiple myeloma

GSK's corporate headquarters in Brentford, London. (Credit: GlaxoSmithKline plc / SmugMug+Flickr)
August 5, 2020

ReViral secures FDA fast track status for sisunatovir to treat severe RSV infection

The US FDA’s Centre for Drug Evaluation and Research. (Credit: The U.S. Food and Drug Administration)

Contracts

July 23, 2020

Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate

US govt signs $1.95bn deal with Pfizer and BioNTech for supply of their Covid-19 vaccine candidate. (Credit: Coolcaesar/Wikipedia.org)

Takeda gets expanded EC approval for lymphoma drug Adcetris

Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials in alopecia areata

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Deals

Deals July 22, 2020

Gilead Sciences to buy 49.9% stake in Tizona Therapeutics for $300m

Pharmaceutical Business Review

JW Therapeutics acquires Syracuse and license to Eureka’s solid tumour technology in China

GSK to acquire 10% stake in German biotech company CureVac

Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m

Popular

  1. Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
  2. Roche’s tocilizumab fails to achieve primary endpoints for Covid-19-related pneumonia
  3. DFC grants $765m loan to Kodak to establish new pharma business unit
  4. Pfizer, BioNTech begin phase 2/3 Covid-19 trial with BNT162b2 vaccine candidate
  5. Daiichi Sankyo, AstraZeneca sign $6bn worth deal for DS-1062

PRESS RELEASES

Securing your end-to-end supply chain
Securing your end-to-end supply chain
Pharmaceutical Business Review
A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels
Pharmaceutical Business Review
LTS and LIVZON Enter License and Collaboration Agreement to Develop and Commercialize ASENAPINE TTS
Pharmaceutical Business Review
Procaps, Valued by the Colombian Ministry of Science as a Highly Innovative Company
7P Solutions Hires Senior Level New Business Development Executive to Help Manage Growth and Additional Sales
7P Solutions Hires Senior Level New Business Development Executive to Help Manage Growth and Additional Sales

Suppliers

Whitepapers

7000RMS Services
7000RMS Services
Software of clairvoyance, structure and reliability
Software of clairvoyance, structure and reliability
Effective and Fast Approval of Incident Investigation Reports
Effective and Fast Approval of Incident Investigation Reports